Abstract
Optimizing photodynamic therapy involves attempting to increase both the absolute tumour content of photosensitizer and the selectivity between tumour and surrounding normal tissue. One reason why photodynamic therapy has not been considered suitable for treatment of metastatic tumours in the liver, is the poor selectivity of conventional photosensitizers for tumour compared to normal liver. This report details an alternative approach to increasing this selectivity by the use of antibody-targeted photosensitizers (or photoimmunoconjugates) to target intrahepatic tumours caused by human colorectal cancer cells in the nude mouse, and explores the role of molecular charge on the tumour-targeting efficiency of macromolecules. The murine monoclonal antibody 17.1A (which recognizes an antigen expressed on HT 29 cells) was used to prepare site-specific photoimmunoconjugates with the photosensitizer chlorine6. The conjugates had either a predominant cationic or anionic charge and were injected i.v. into tumour-bearing mice. Biodistribution 3 or 24 h later was measured by extraction of tissue samples and quantitation of chlorine6 content by fluorescence spectroscopy. The photoimmunoconjugates were compared to the polylysine conjugates in an attempt to define the effect of molecular charge as well as antibody targeting. The anionic 17.1A conjugate delivered more than twice as much photosensitizer to the tumour at 3 h than other species (5 times more than the cationic 17.1A conjugate) and had a tumour:normal liver ratio of 2.5. Tumour-to-liver ratios were greater than one for most compounds at 3 h but declined at 24 h. Tumour-to-skin ratios were high (> 38) for all conjugates but not for free chlorine6. Cationic species had a high uptake in the lungs compared to anionic species. The photoimmunoconjugates show an advantage over literature reports of other photosensitizers, which can result in tumour:normal liver ratios of less than 1. © 2000 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Baas P, van Mansom I, van Tinteren H, Stewart FA and van Zandwijk N (1995 Effect of N-acetylcysteine on Photofrin-induced skin photosensitivity in patients. Lasers Surg Med 16: 359–367
Del Governatore M, Hamblin MR, Piccinini EE, Ugolini G and Hasan T (2000a Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer 82: 56–64
Del Governatore M, Hamblin MR, Shea CR, Rizvi I, Molpus KL, Tanabe K and Hasan T (2000b Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1 A chlorin e6 immunoconjugate. Cancer Res 60: 4200–4205
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q (1998 Photodynamic therapy. J Natl Cancer Inst 90: 889–905
Duewell S, Horst W and Westera G (1986 Uptake of a monoclonal antibody against CEA (Tumak 431/31) in a human colon tumor (Co-112) xenografted in the nude mouse. Dependence on tumor size and injected dose. Cancer Immunol Immunother 23: 101–106
Duska LR, Hamblin MR, Bamberg MP and Hasan T (1997 Biodistribution of charged F(ab´)2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer 75: 837–844
Ekrami H, Kennedy AR and Shen WC (1995 Disposition of positively charged Bowman-Birk protease inhibitor conjugates in mice: influence of protein conjugate charge density and size on lung targeting. J Pharm Sci 84: 456–461
Goff BA, Bamberg MP and Hasan T (1992 Experimental photodynamic treatment of ovarian cancer cells with immunoconjugates. Antibody Immunocon Radiopharm 5: 191–199
Goff BA, Hermanto U, Rumbaugh J, Blake J, Bamberg M and Hasan T (1994 Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer 70: 474–480
Goff BA, Blake J, Bamberg MP and Hasan T (1996 Treatment of ovarian cancer with photodynamic therapy and immunconjugates in a murine ovarian cancer model. Br J Cancer 74: 1194–1198
Gottlinger HG, Funke I, Johnson JP, Gokel JM and Riethmuller G (1986 The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer 38: 47–53
Hamblin MR, Miller JL and Hasan T (1996 The effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res 56: 5205–5210
Hasan T (1992 Photosensitizer delivery mediated by macromolecular carrier systems. Henderson B, Dougherty T (eds), Photodynamic Therapy: Basic Principles and Clinical Applications, Marcel Dekker: New York, NY pp 187–200
Klyashchitsky BA, Nechaeva IS and Ponomaryov GV (1994 Approaches to targetted photodynamic therapy. J Control Release 29: 1–16
Kornguth SE, Kalinke T, Robins HI, Cohen JD and Turski P (1989 Preferential binding of radiolabeled poly-L-lysines to C6 and U87 MG glioblastomas compared with endothelial cells in vitro. Cancer Res 49: 6390–6395
Kornguth S, Lohmiller S, Kalinke T, Robins HI, Kyritsis A, Turski P, Cohen J, Nickles RJ and DeJesus O (1991 Biodistribution of polylysine-guided radionuclides. Epenetos A (eds), Monoclonal Antibodies, Chapman & Hall Medical: London 133–147
Litvinov SV, Velders MP, Bakker HA, Fleuren GJ and Warnaar SO (1994 Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125: 437–446
Meredith RF, Khazaeli MB, Plott WE, Spencer SA, Wheeler RH, Brady LW, Woo DV and LoBuglio AF (1995 Initial clinical evaluation of iodine- 125-labeled chimeric 17-1A for metastatic colon cancer. J Nucl Med 36: 2229–2233
Mew D, Wat CK, Towers GH and Levy JG (1983 Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol 130: 1473–1477
Nieroda CA, Mojzisik C, Hinkle G, Thurston MO and Martin EW Jr (1991 Radioimmunoguided surgery (RIGS) in recurrent colorectal cancer. Cancer Detect Prev 15: 225–229
Nishiwaki Y, Nakamura S and Sakaguchi S (1989 New method of photosensitizer accumulation for photodynamic therapy in an experimental liver tumor. Lasers Surg Med 9: 254–263
Orenstein A, Kostenich G, Roitman L, Shechtman Y, Kopolovic Y, Ehrenberg B and Malik Z (1996 A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Br J Cancer 73: 937–944
Pardridge WM, Buciak J, Yang J and Wu D (1998 Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein. J Pharmacol Exp Ther 286: 548–554
Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H and Pichlmayr R (1994 Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 343: 1177–1183
Rougier P (1998 Are there indications for intraarterial hepatic chemotherapy or isolated liver perfusion? The case of liver metastases from colorectal cancer. Recent Results Cancer Res 147: 3–12
Rovers JP, Saarnak AE, Sterenborg HJ, Grahn MF and Terpstra OT (1999 Increased selectivity and uptake of Foscan (mTHPC) in a rat liver tumor model by hepatic artery administration. European Society for Photobiology, Granada: Spain 123
Sato N, Saga T, Sakahara H, Yao Z, Nakamoto Y, Zhang M, Kuroki M, Matsuoka Y, Iida Y and Konishi J (1999 Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse. J Nucl Med 40: 685–692
Schmidt S, Wagner U, Oehr P and Krebs D (1992a Clinical use of photodynamic therapy in gynecologic tumor patients – antibody-targeted photodynamic laser therapy as a new oncologic treatment procedure. Zentralbl Gynakol 114: 307–311
Schmidt S, Wagner U, Schultes B, Oehr P, Decleer W, Ertmer W, Lubaschowski H, Biersack HJ and Krebs D (1992b Photodynamic laser therapy with antibody-bound dyes. A new procedure in therapy of gynecologic malignancies. Fortschr Med 110: 298–301
Steele G Jr and Ravikumar TS (1989 Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210: 127–138
Tralau CJ, Young AR, Walker NP, Vernon DI, MacRobert AJ, Brown SB and Bown SG (1989 Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and aluminium sulphonated phthalocyanine (AISPc): a comparative study. Photochem Photobiol 49: 305–312
Van Cutsem E (1996 A glimpse of the future, new directions in the treatment of colorectal cancer. Eur J Cancer 32AS: 23–27
van Hillegersberg R, Marijnissen JP, Kort WJ, Zondervan PE, Terpstra OT and Star WM (1992a Interstitial photodynamic therapy in a rat liver metastasis model. Br J Cancer 66: 1005–1014
Van Hillegersberg R, Van den Berg JW, Kort WJ, Terpstra OT and Wilson JH (1992b Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 103: 647–651
van Hillegersberg R, Pickering JW, Aalders M and Beek JF (1993 Optical properties of rat liver and tumor at 633 nm and 1064 nm: photofrin enhances scattering. Lasers Surg Med 13: 31–39
Weagle G, Paterson PE, Kennedy J and Pottier R (1988 The nature of the chromophore responsible for naturally occurring fluorescence in mouse skin. J Photochem Photobiol B 2: 313–320
Woodburn KW, Stylli S, Hill JS, Kaye AH, Reiss JA and Phillips DR (1992 Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy. Br J Cancer 65: 321–328
Yarmush ML, Thorpe WP, Strong L, Rakestraw SL, Toner M and Tompkins RG (1993 Antibody targeted photolysis. Crit Rev Ther Drug Carrier Syst 10: 197–252
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hamblin, M., Governatore, M., Rizvi, I. et al. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer 83, 1544–1551 (2000). https://doi.org/10.1054/bjoc.2000.1486
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1486
Keywords
This article is cited by
-
The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy
British Journal of Cancer (2005)